Company / Operating Cash Flow
ABEONA THERAPEUTICS INC. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$76.3M
FY2025
5-year range
-$76.3M / -$35.0M
FY2021-FY2025
Trend
-106.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$76M in FY2025 to -$10M in FY2016.
Based on SEC 10-K filings.
-$76M in FY2025.
Declined from -$43M to -$76M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 106.2% year-over-year.
- Peak operating cash flow was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$76.3M | -106.2% |
| FY2024 | -$37.0M | +14.9% |
| FY2023 | -$43.5M | +33.8% |
| FY2022 | -$65.7M | -87.5% |
| FY2021 | -$35.0M | +44.3% |
| FY2020 | -$62.8M | -177.3% |
| FY2019 | -$22.7M | +42.1% |
| FY2018 | -$39.1M | -72.6% |
| FY2017 | -$22.7M | -117.4% |
| FY2016 | -$10.4M | -547.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026